Chemotherapy Synergizes with Radioimmunotherapy Targeting La Autoantigen in Tumors
Fares Al-Ejeh, Jocelyn M. Darby, Michael P. Brown · 2009
Read Chemotherapy Synergizes with Radioimmunotherapy Targeting La Autoantigen in Tumors by Fares Al-Ejeh, Jocelyn M. Darby, Michael P. Brown (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004630.txt.
Description
Chemotherapy helps antibody-guided radiation find its tumor targets, show Fares Al-Ejeh, Jocelyn Darby, and Michael Brown in PLOS ONE in 2009. Radioimmunotherapy uses antibodies to carry radioactive atoms to tumors. Its clinical utility is limited by inefficient delivery of therapeutic doses of radiation to solid tumors.
The antibody targets the La autoantigen, exposed on dead and dying tumor cells, as the team's earlier work showed. They aimed to test the therapeutic utility of yttrium-90 radio-conjugates of that antibody. Chemotherapy synergizes with the treatment, on their evidence: killing some tumor cells first exposes more target for the antibody. A combination that makes each part work better is exactly what solid tumor therapy needs.
Catalog record
| CREATOR | Fares Al-Ejeh, Jocelyn M. Darby, Michael P. Brown |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004630